Publications by authors named "M Kind"

Claim this Profile
B
Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer.
Ghina Jardali, Littisha Lawrance, Lama Dawi, Jules Dupont, Othilie Gautier, Michèle Kind

Diagn Interv Imaging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Report of the Working Group on Gynecological and Breast Pathology of the German Society of Pathology : 2025 DGP Annual Conference].
Eike Burandt, Marcus Kind, Ramona Erber

Pathologie (Heidelb)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Transformation Processes in Coprecipitated Cu/Zn/Zr Methanol Catalyst Precursors-Insights into Suspension Aging Form Ultrafast Nucleation.
Lucas Warmuth, Thomas A Zevaco, David Guse, Michael Zimmermann, Matthias Kind

Chempluschem· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab.
Maud Toulmonde, Jean-Philippe Guégan, Mariella Spalato-Ceruso, Thibaud Valentin, Rastilav Bahleda, Michèle Kind

Signal Transduct Target Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis.
Sophie Cousin, Jean-Philippe Guégan, Lola Jade Palmieri, Jean Philippe Metges, Simon Pernot, Michèle Kind

Nat Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis